Cipla’s arm inks pact to acquire 26% stake in AMPIN Energy C&I Eighteen

20 May 2025 Evaluate

Cipla’s subsidiary -- Jay Precision Pharmaceuticals has entered into Share Purchase, Subscription and Shareholder’s Agreement (SPSSA) to acquire 26% stake on a fully diluted basis in AMPIN Energy C&I Eighteen, for setting up captive solar power project in Maharashtra. This in line with the commitment to enhance the share of renewable power source in its operation and to comply with regulatory requirement for being a ‘captive user’ under Indian electricity laws.

The total consideration to be paid for the said acquisition is up to Rs 1.46 crore and the subscription to equity shares is expected to be completed within 1 month from the date of the signing of the transaction documents, or by such other date as maybe mutually agreed between the parties. Post transaction, the company’s stake in AMPIN Energy C&I Eighteen would be 26% on a fully diluted basis.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1520.00 -1.20 (-0.08%)
05-Dec-2025 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.50
Dr. Reddys Lab 1274.50
Cipla 1520.00
Zydus Lifesciences 930.75
Lupin 2098.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×